文献速递免疫规划营养与食品安全妇幼与学校卫生

轮状病毒疫苗推广与坦桑尼亚儿童发育迟缓:超越疾病预防

Beyond disease prevention: rotavirus vaccine rollout and child stunting in Tanzania.
PubMed 文献 · Vaccine · 2026-09-28

研究利用2015/16年坦桑尼亚人口与健康调查8949名儿童数据,采用回归断点设计(RDD)和中断时间序列分析(ITSA),评估轮状病毒疫苗推广对身高别年龄Z评分(HAZ)的影响。结果显示疫苗合格儿童平均HAZ为-1.34,不合格儿童为-1.65(差值0.31 SD,p<.001);二次RDD在资格阈值处HAZ增益0.44 SD(含协变量0.36 SD),局部线性模型为0.22-0.26 SD;ITSA显示即时增益0.38-0.42 SD并呈持续正趋势。结论认为疫苗推广与发育迟缓减少相关,建议优先覆盖零剂次和接种不足儿童,整合疫苗接种与母婴营养服务并维持疫苗筹资。

要点

  • 轮状病毒疫苗推广与儿童HAZ改善及发育迟缓减少相关。
  • RDD估计资格阈值处HAZ增益0.44 SD,ITSA显示即时增益0.38-0.42 SD。
  • 政策应优先零剂次和接种不足儿童,整合疫苗与母婴营养服务。

核心结论

  • 坦桑尼亚引入轮状病毒疫苗与通过改善长期生长结局减少发育迟缓相关。
  • 疫苗接种提供超越感染预防的效益,是对人力资本的投资。

研究设计与样本

  • 利用2015/16年坦桑尼亚人口与健康调查(TDHS),样本为8949名儿童。

主要发现

  • 疫苗合格儿童平均HAZ为-1.34,不合格儿童为-1.65(差值0.31 SD,p<.001)。
  • 首选二次RDD显示资格阈值处HAZ增益0.44 SD(含协变量0.36 SD);局部线性模型为0.22-0.26 SD。
  • ITSA显示即时增益0.38-0.42 SD,并呈持续正趋势。
  • 安慰剂 cutoff 和证伪结局表明效应非由混杂因素驱动。

临床怎么用

  • 政策应优先覆盖零剂次和接种不足儿童。
  • 将疫苗接种与母婴和营养服务整合。
  • 维持疫苗筹资。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tanzania introduced the rotavirus vaccine in January 2013 to reduce the burden of diarrheal disease, a driver of malnutrition. While the vaccine's effect on diarrheal morbidity and mortality is well established, limited evidence exists on its broader effect on child growth outcomes, particularly stunting which affects about 30% of Tanzanian children under five. METHODS: Using data from the 2015/16 Tanzania Demographic and Health Survey (TDHS) with a sample of 8949 children, this study applies a reduced-form Regression Discontinuity Design (RDD) exploiting the vaccine eligibility cutoff (children born ≥ November 2012) and Interrupted Time Series Analysis (ITSA) to estimate both immediate and sustained effects of the vaccine rollout on height-for-age z-score (HAZ). RESULTS: Mean HAZ was -1.34 among vaccine-eligible children and - 1.65 among ineligible children (difference 0.31 SD, p < .001). The preferred quadratic RDD suggests a 0.44 SD gain in HAZ at the eligibility threshold (0.36 SD with covariates); local linear models indicate 0.22-0.26 SD. ITSA shows an immediate gain of 0.38-0.42 SD and a sustained positive post-rollout trend. Placebo cutoffs and falsification outcomes suggest that the effects are not driven by confounding factors. CONCLUSION: The introduction of the rotavirus vaccine in Tanzania is associated with reductions in stunting by improving long-term growth outcomes. These findings suggest that vaccination provides benefits beyond infection prevention, serving as an investment in human capital. Policy should prioritise zero-dose and under-vaccinated children, integrate vaccination with maternal and nutrition services and sustain vaccine financing.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mwaseba SL, Burger R, von Fintel D, et al. Beyond disease prevention: rotavirus vaccine rollout and child stunting in Tanzania. Vaccine. 2026. PMID: 42805052. doi:10.1016/j.vaccine.2026.129210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。